UBS Group’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $718K | Sell |
472,042
-18,158
| -4% | -$27.6K | ﹤0.01% | 4585 |
|
|
2025
Q1 | $679K | Buy |
490,200
+55,643
| +13% | +$77.1K | ﹤0.01% | 4462 |
|
|
2024
Q4 | $986K | Buy |
434,557
+411,783
| +1,808% | +$935K | ﹤0.01% | 4214 |
|
|
2024
Q3 | $107K | Sell |
22,774
-45,799
| -67% | -$216K | ﹤0.01% | 5122 |
|
|
2024
Q2 | $513K | Sell |
68,573
-140,903
| -67% | -$1.05M | ﹤0.01% | 3901 |
|
|
2024
Q1 | $3.57M | Buy |
209,476
+70,831
| +51% | +$1.21M | ﹤0.01% | 2493 |
|
|
2023
Q4 | $3.15M | Buy |
138,645
+103,662
| +296% | +$2.35M | ﹤0.01% | 2430 |
|
|
2023
Q3 | $532K | Buy |
34,983
+20,063
| +134% | +$305K | ﹤0.01% | 3554 |
|
|
2023
Q2 | $193K | Buy |
14,920
+13,300
| +821% | +$172K | ﹤0.01% | 4473 |
|
|
2023
Q1 | $13.4K | Buy |
1,620
+74
| +5% | +$612 | ﹤0.01% | 6306 |
|
|
2022
Q4 | $14.3K | Sell |
1,546
-48,454
| -97% | -$448K | ﹤0.01% | 6897 |
|
|
2022
Q3 | $33K | Buy |
+50,000
| New | +$33K | ﹤0.01% | 5674 |
|
|
2021
Q4 | – | Sell |
-964
| Closed | -$12K | – | 9118 |
|
|
2021
Q3 | $12K | Buy |
964
+741
| +332% | +$9.22K | ﹤0.01% | 6603 |
|
|
2021
Q2 | $2K | Sell |
223
-718
| -76% | -$6.44K | ﹤0.01% | 7816 |
|
|
2021
Q1 | $10K | Sell |
941
-996
| -51% | -$10.6K | ﹤0.01% | 6887 |
|
|
2020
Q4 | $24K | Buy |
1,937
+1,772
| +1,074% | +$22K | ﹤0.01% | 5790 |
|
|
2020
Q3 | $2K | Sell |
165
-4,384
| -96% | -$53.1K | ﹤0.01% | 6749 |
|
|
2020
Q2 | $51K | Buy |
4,549
+691
| +18% | +$7.75K | ﹤0.01% | 4999 |
|
|
2020
Q1 | $28K | Sell |
3,858
-4,184
| -52% | -$30.4K | ﹤0.01% | 5362 |
|
|
2019
Q4 | $112K | Buy |
+8,042
| New | +$112K | ﹤0.01% | 4917 |
|